Discovery and Developmental Therapeutics
The Discovery and Developmental Therapeutics (DDT) Program is the primary driver of discovery and evaluation of novel therapeutic options for patients with cancer at the Winship Cancer Institute.
The DDT Program has developed and recruited expertise focused on four specific interconnected goals: 1) to identify small molecule cancer therapeutics; 2) to translate discoveries in cancer immunology into enhanced therapies; 3) to develop innovative in vivo imaging technologies; and 4) to accelerate targeted therapeutics into clinical trials.
View recent publications by DDT Program members
To find out more about this research program, email program leader Haian Fu, PhD at firstname.lastname@example.org.
Learn about our Cancer Biology Graduate Program by visiting our website.